PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$1.44B
1-Year Return
6.39%
This Quarter Return
+2.37%
1 Year Return
+6.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.77B
AUM Growth
+$467M
(+36%)
Cap. Flow
+$446M
Cap. Flow
% of AUM
25.26%
Top 10 Holdings %
Top 10 Hldgs %
19.38%
Holding
1,826
New
503
Increased
291
Reduced
226
Closed
774
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$121M |
| 2 |
NVIDIA
NVDA
|
+$31.8M |
| 3 |
Cigna
CI
|
+$25.8M |
| 4 |
Lowe's Companies
LOW
|
+$25M |
| 5 |
Visa
V
|
+$24.1M |
Top Sells
| 1 |
American International
AIG
|
+$15.4M |
| 2 |
Advanced Micro Devices
AMD
|
+$15.3M |
| 3 |
Booking.com
BKNG
|
+$14.2M |
| 4 |
Merck
MRK
|
+$13.4M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$12.6M |
Sector Composition
| 1 | Technology | 18.25% |
| 2 | Healthcare | 14% |
| 3 | Consumer Discretionary | 13.5% |
| 4 | Financials | 11.82% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Mammoth Energy Services
TUSK
$115M
| $16.4K | ﹤0.01% |
+3,894
| New | +$16.4K |
|
902
Carpenter Technology
CRS
$12.1B
| $16.1K | ﹤0.01% |
360
-2,199
| -86% | -$98.3K |
|
903
NETGEAR
NTGR
$842M
| $16.1K | ﹤0.01% |
+869
| New | +$16.1K |
|
|
NPKI
904
NPK International Inc.
NPKI
$901M
| $15.8K | ﹤0.01% |
4,100
+2,342
| +133% | +$9.02K |
|
905
Inspire Medical Systems
INSP
$2.45B
| $15.6K | ﹤0.01% |
+67
| New | +$15.6K |
|
906
Ovid Therapeutics
OVID
$88.9M
| $15.5K | ﹤0.01% |
+5,993
| New | +$15.5K |
|
907
Sutro Biopharma
STRO
$82.2M
| $15.2K | ﹤0.01% |
+3,281
| New | +$15.2K |
|
908
Byrna Technologies
BYRN
$461M
| $15.2K | ﹤0.01% |
+1,996
| New | +$15.2K |
|
909
Cohu
COHU
$992M
| $14.6K | ﹤0.01% |
381
-4,465
| -92% | -$171K |
|
910
Universal Electronics
UEIC
$64M
| $14.6K | ﹤0.01% |
+1,441
| New | +$14.6K |
|
|
KG
911
Kestrel Group, Ltd.
KG
$203M
| $14.4K | ﹤0.01% |
+345
| New | +$14.4K |
|
912
Tango Therapeutics
TNGX
$761M
| $14.2K | ﹤0.01% |
+3,583
| New | +$14.2K |
|
913
Inogen
INGN
$231M
| $14.1K | ﹤0.01% |
+1,132
| New | +$14.1K |
|
914
AdvanSix
ASIX
$586M
| $14K | ﹤0.01% |
+367
| New | +$14K |
|
915
Aon
AON
$80.3B
| $13.9K | ﹤0.01% |
44
-12,068
| -100% | -$3.8M |
|
916
Acumen Pharmaceuticals
ABOS
$84.2M
| $13.9K | ﹤0.01% |
+3,415
| New | +$13.9K |
|
917
Astronics
ATRO
$1.43B
| $13.8K | ﹤0.01% |
+1,030
| New | +$13.8K |
|
918
Oportun Financial
OPRT
$278M
| $13.5K | ﹤0.01% |
3,485
+1,164
| +50% | +$4.49K |
|
919
Enviri
NVRI
$987M
| $13.3K | ﹤0.01% |
1,948
-4,701
| -71% | -$32.1K |
|
920
Costamare
CMRE
$1.47B
| $13K | ﹤0.01% |
1,377
-9,178
| -87% | -$86.4K |
|
921
Xometry
XMTR
$2.57B
| $12.9K | ﹤0.01% |
860
-6,237
| -88% | -$93.3K |
|
922
CVRx
CVRX
$215M
| $12.7K | ﹤0.01% |
+1,365
| New | +$12.7K |
|
|
ATRI
923
DELISTED
Atrion Corp
ATRI
| $12.6K | ﹤0.01% |
+20
| New | +$12.6K |
|
924
Fulcrum Therapeutics
FULC
$378M
| $12.3K | ﹤0.01% |
+4,311
| New | +$12.3K |
|
|
ITOS
925
DELISTED
iTeos Therapeutics
ITOS
| $12.2K | ﹤0.01% |
+900
| New | +$12.2K |
|